J. Jeffrey Goater
2021
In 2021, J. Jeffrey Goater earned a total compensation of $932.6K as Director, former Chief Executive Officer, President and Senior Advisor at Surface Oncology, a 60% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $181,423 |
|---|---|
| Option Awards | $374,157 |
| Salary | $364,575 |
| Other | $12,477 |
| Total | $932,632 |
Goater received $374.2K in option awards, accounting for 40% of the total pay in 2021.
Goater also received $181.4K in non-equity incentive plan, $364.6K in salary and $12.5K in other compensation.
Rankings
In 2021, J. Jeffrey Goater's compensation ranked 9,008th out of 12,415 executives tracked by ExecPay. In other words, Goater earned more than 27.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,008 out of 12,415 | 27th |
Division Manufacturing | 3,998 out of 5,505 | 27th |
Major group Chemicals And Allied Products | 1,756 out of 2,375 | 26th |
Industry group Drugs | 1,561 out of 2,096 | 26th |
Industry Biological Products, Except Diagnostic Substances | 340 out of 449 | 24th |
Source: SEC filing on April 26, 2022.
Goater's colleagues
We found three more compensation records of executives who worked with J. Jeffrey Goater at Surface Oncology in 2021.